Your browser doesn't support javascript.
loading
Phase II trial of dose dense docetaxel followed by FEC100 as neoadjuvant chemotherapy in patients with operable breast cancer.
Jacot, William; Bibeau, Frédéric; Gourgou-Bourgade, Sophie; Gutowski, Marian; Colombo, Pierre-Emmanuel; Bleuse, Jean-Pierre; Kramar, Andrew; Romieu, Gilles.
Affiliation
  • Jacot W; CRLC Val d'Aurelle, Montpellier, France. william.jacot@valdorel.fnclcc.fr
Am J Clin Oncol ; 33(6): 544-9, 2010 Dec.
Article in En | MEDLINE | ID: mdl-20042972

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Year: 2010 Type: Article

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Year: 2010 Type: Article